Trump announces trade deal with EU following months of negotiations
Nicole S. Jones, the Executive Vice President, Chief Administrative Officer, and General Counsel at Cigna Group (NYSE:CI), a healthcare giant with $247 billion in revenue and strong financial health according to InvestingPro analysis, recently sold shares worth approximately $1.51 million. This transaction was executed under a pre-established trading plan on March 3, 2025. The shares were sold at an average price of $308.12 each, with the company currently appearing undervalued based on InvestingPro’s Fair Value model.
In addition to the stock sale, Jones also conducted transactions related to tax obligations. On February 28, 2025, she had shares withheld to cover tax liabilities upon the vesting of restricted shares and the settlement of strategic performance shares, amounting to a total of $1,562,638 at a price of $305.86 per share.
Jones’s recent transactions reflect her ongoing management of her equity stake in the company, which also includes acquisitions through awards and participation in the company’s 401(k) plan.
In other recent news, Cigna Corporation has reported a significant earnings shortfall for the fourth quarter of 2024, with adjusted earnings per share (EPS) of $6.64, falling short of the consensus estimate of $7.82. This shortfall is primarily due to higher-than-expected costs in its Stop-Loss insurance, driven by increased specialty drug expenses and high-acuity surgical procedures. As a result, Piper Sandler has reduced Cigna’s stock price target from $394 to $348, although it maintains an Overweight rating. Similarly, RBC Capital Markets lowered its price target from $377 to $355, citing challenges with high specialty drug costs and inpatient acuity affecting the medical care ratio (MCR) for 2025.
In response to these challenges, Cigna has announced executive changes aimed at improving health outcomes and customer satisfaction. The company plans to link executive compensation to customer satisfaction improvements and will publish an annual Customer Transparency Report starting in 2026. Additionally, Evernorth Health Services, part of The Cigna Group, is implementing measures to protect patients from high medication prices.
The healthcare sector has also been influenced by broader market developments, such as President Trump’s supportive comments on social security, Medicare, and Medicaid, which have been perceived positively by investors. Despite facing scrutiny from a Department of Justice investigation into Medicare billing practices, which has impacted the sector, Cigna and its peers have experienced varied stock performance. As these developments unfold, investors remain attentive to further updates from the company and regulatory bodies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.